Percutaneous valve implantation: new valves and new indications

Presentations available when logged in:

  • 45-day outcome of TAVI of the lowest profile pre-package and sterilised aortic valve in the world
  • Improved aortic valve haemodynamics following TAVI with a novel, retrievable and fully repositionable device
  • First report of 1-year outcomes of the REPRISE I feasibility study of the repositionable Lotus aortic valve replacement system
  • Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards sapien XT bioprosthesis: first-in-man experience
  • Implantation of a second-generation transcatheter heart valve in patients with non-calcified aortic regurgitation